Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Someya

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissuesK Imaoka, C J Miller, M Kubota, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patientsN Nagai, M Kinoshita, H Ogata, et al.
The Journal of General Virology|June 4, 1999
A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkeyK Shinohara, K Sakai, S Ando, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|January 25, 2002
[Clinical evaluation of an immunochromatography test for rapid diagnosis of influenza]M Yamazaki, K Mitamura, K Kimura, et al.
Archives of Gerontology and Geriatrics|September 18, 2004
Prevalence of senile dementia in a rural community in Japan: the Tajiri projectH Ishii, K Meguro, J Ishizaki, et al.
Gene Therapy|August 5, 2005
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIVK-Q Xin, N Jounai, K Someya, et al.
Journal of Clinical Pharmacology|November 24, 1998
Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: analysis with the NONMEM programN Nagai, H Ogata, Y Wada, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissuesK Imaoka, C J Miller, M Kubota, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patientsN Nagai, M Kinoshita, H Ogata, et al.
The Journal of General Virology|June 4, 1999
A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkeyK Shinohara, K Sakai, S Ando, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|January 25, 2002
[Clinical evaluation of an immunochromatography test for rapid diagnosis of influenza]M Yamazaki, K Mitamura, K Kimura, et al.
Archives of Gerontology and Geriatrics|September 18, 2004
Prevalence of senile dementia in a rural community in Japan: the Tajiri projectH Ishii, K Meguro, J Ishizaki, et al.
Gene Therapy|August 5, 2005
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIVK-Q Xin, N Jounai, K Someya, et al.
Journal of Clinical Pharmacology|November 24, 1998
Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: analysis with the NONMEM programN Nagai, H Ogata, Y Wada, et al.
Pageof 10